✦ LIBER ✦

TUMOR SIZE IS ASSOCIATED WITH MALIGNANT POTENTIAL IN RENAL CELL CARCINOMA

✍ Scribed by Kurta, Jordan M; Thompson, R Houston; Kaag, Matt; Tickoo, Satish K; Kundu, Shilajit D; Katz, Darren J; Nogueira, Lucas; Reuter, Victor E; Russo, Paul

Book ID: 122463365
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)60616-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor Size is Associated With Malignant

Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma Cases

✍ Thompson, R. Houston; Kurta, Jordan M.; Kaag, Matthew; Tickoo, Satish K.; Kundu, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 143 KB

Inflammatory myofibroblastic tumor assoc

Inflammatory myofibroblastic tumor associated with renal cell carcinoma

✍ Eric S. Gwynn; Peter E. Clark 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 167 KB

INCREASING TUMOR SIZE IS ASSOCIATED WITH

INCREASING TUMOR SIZE IS ASSOCIATED WITH HIGHER RATES OF HIGH FUHRMAN NUCLEAR GRADE IN PATIENTS WITH RENAL CELL CARCINOMA

✍ Jeldres, Claudio; Suardi, Nazareno; Bhojani, Naeem; Patard, Jean-Jacques; Bensal 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 181 KB

Metachronous Metastatic Potential of Sma

Metachronous Metastatic Potential of Small Renal Cell Carcinoma: Dependence on Tumor Size

✍ Ja Hyeon Ku; Kyung Chul Moon; Cheol Kwak; Hyeon Hoe Kim 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Renal Cell Carcinoma as Second Malignanc

Renal Cell Carcinoma as Second Malignancy in Patient With Previous Wilms Tumor

✍ John Lazarus; Conray Moolman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Tumor-associated trypsin inhibitor in no

Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients

✍ Annukka Lukkonen; Susanna Lintula; Kristina von Boguslawski; Olli Carpén; Börje 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 415 KB 👁 2 views

Tumor-associated trypsin inhibitor (TATI) is a 6-kDa peptide, which is identical to the pancreatic-secretory-trypsin inhibitor (PSTI). TATI is produced by several tumors and cancer cell lines, and is used as a serum marker for mucinous ovarian cancer. Elevated serum levels of TATI have also been obs